UnknownNot Applicable

Treatment Effect of Cross-frequency Transcranial Alternating Current Stimulation on the MUD

China32 participantsStarted 2023-10-15

Plain-language summary

The purpose of this research is to evaluate the efficacy of multiple sessions of theta-gamma cross-frequency transcranial alternating current stimulation in patients with methamphetamine (MA) use disorders.

Who can participate

Age range

18 Years – 59 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
. Normal vision and hearing
. Dextromanual
. Use MA not less than 1 year, and the last of MA use no less than 3 months

Exclusion criteria

. Have a disease that affects cognitive function such as a history of head injury, cerebrovascular disease, epilepsy, etc
. Have cognitive-promoting drugs in the last 6 months
. Other substance abuse or dependence in recent five years (except nicotine)
. Meet the DSM-5 criteria for other mental disorders
. Physical disease

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change of Craving assessed by Visual Analog Scale

Timeframe: baseline，0-2 days after treatment，1 months after treatment, 3 months after treatment

Trial details

NCT IDNCT06145698

SponsorShanghai Mental Health Center

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2024-01-15

Contact for this trial

Min Zhao, PhD

021-54252689 18017311005@163.com

View on ClinicalTrials.gov More Amphetamine-Related Disorders trials